Laman UtamaTORNTPHARM • NSE
add
Torrent Pharmaceuticals Ltd
Tutup sebelumnya
₹3,583.60
Julat hari
₹3,558.20 - ₹3,599.90
Julat tahun
₹2,886.45 - ₹3,787.90
Permodalan pasaran
1.21T INR
Bilangan Purata
232.01K
Nisbah P/E
60.19
Hasil dividen
0.90%
Pertukaran utama
NSE
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (INR) | Jun 2025info | Perubahan T/T |
|---|---|---|
Hasil | 31.78B | 11.16% |
Perbelanjaan pengendalian | 15.73B | 9.39% |
Pendapatan bersih | 5.48B | 19.91% |
Margin untung bersih | 17.24 | 7.88% |
Pendapatan bagi setiap syer | 16.19 | 19.84% |
EBITDA | 10.18B | 11.29% |
Kadar cukai berkesan | 25.75% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (INR) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 6.88B | -31.48% |
Jumlah aset | — | — |
Jumlah liabiliti | — | — |
Jumlah ekuiti | 75.91B | — |
Syer tertunggak | 338.48J | — |
Harga kepada buku | 15.98 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 19.16% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (INR) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 5.48B | 19.91% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Torrent Pharmaceuticals Ltd, d/b/a Torrent Pharma, is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals operates in more than 40 countries with over 2,000 product registrations globally. Torrent Pharma is active in the therapeutic areas of cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. It also has a presence in therapeutic segments of nephrology, oncology, gynecology, respiratory and pediatrics. Wikipedia
Diasaskan
1959
Ibu pejabat
Tapak web
Pekerja
17,059
